OncoDNA S.A.
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are a group of passionate people who have developed a unique portfiolio of smart and personalized solutions to help you see clear through molecular complexity. You can rely on our extensive expertise in genomics and theranostics to collect, explore and interpret the tons of complex data that you need for your research project, clinical trials or clinical decision-making. Together, we can bring therapeutic innovation to the clinics and deliver the best of care to patients.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
Welcome
ACADEMIC RESEARCHERS
We are dedicated to helping you drive innovation in cancer and genetic diseases. Through a variety of NGS, molecular profiling and data interpretation services, we can deliver the robust, accurate and reliable data that you need to conduct research projects in a rapid and cost-efficient manner.
BIOPHARMA
Our services focus on helping you to accelerate drug development by providing valuable and high-quality molecular insights in a fast turnaround time to fully characterize a patient, facilitate patient matching to clinical trials and monitor therapeutic response in real time.
PHYSICIANS
Treating late stage tumors or cancer of unknown primary can be challenging. Our biomarker testing solutions are designed to help you spot the molecular weaknesses of an individual cancer, predict resistance to therapies, identify the most effective treatment options and monitor your patient's response to therapy in real time.
Our Commitment
IMPROVING PATIENTS' HEALTH THROUGH PRECISION CARE
At OncoDNA, we are a group of passionate people who are bound and led by the desire of revolutionizing the way patients diagnosed with a cancer or a genetic disease are treated. Our ultimate mission is to be able to improve all patients’ health by empowering physicians, biopharma companies and researchers to deliver the promise of precision medicine.
With the development of next-generation sequencing technologies, our understanding of the human genome has improved signficantly, leading to a cascade of scientific discoveries and new treatments. Yet, we are still a long way off from finding a universal treatment for genetic diseases such as cancer. At OncoDNA, we believe that we all need to come together and join our forces. Through collaboration, we can have a greater impact on patient care.
In our relentless pursuit of better care, we have been building an ecosystem of partners involved along the entire value chain - from translational research and drug development to patient treatment, monitoring and reimbursement. We deeply value these interactions and we are committed to actively listening to every need and putting the right resources to achieve our mission.
Our Impact
Our solutions have an impact on patients' cancer journey the world over. We are proud to say that our biomarker tests and clinical decision support have informed the treatment of over 22,000 patients. It is motivating to see how they have improved their quality of life and clinical outcomes. View their incredible fight against cancer.